15-PGDH inhibition promotes muscle repair and strength recovery during GLP-1 receptor agonist–induced weight loss
Minas Nalbandian, Jameel Lone, Emmeran Le Moal, Ireh Kim, Kaitlin Jeuris, Yutong Kelly Li, Peggy Kraft, Meng Zhao, Kassie Koleckar, Zeyuan Zhang, Katrin J. Svensson, Helen M. Blau · 2026
Read 15-PGDH inhibition promotes muscle repair and strength recovery during GLP-1 receptor agonist–induced weight loss by Minas Nalbandian, Jameel Lone, Emmeran Le Moal, Ireh Kim, Kaitlin Jeuris, Yutong Kelly Li, Peggy Kraft, Meng Zhao, Kassie Koleckar, Zeyuan Zhang, Katrin J. Svensson, Helen M. Blau (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13250539.txt.
Description
Minas Nalbandian and colleagues present 2026 research on protecting muscle during weight loss caused by GLP-1 drugs. Drugs such as semaglutide produce large weight loss, but part of what patients lose is lean muscle. The study targets an enzyme called 15-PGDH, which breaks down a growth-related signal named prostaglandin.
Blocking this enzyme raised prostaglandin levels and changed how muscle stem cells behaved during drug-induced weight loss. The treated muscle formed new fibers more effectively and recovered strength better than untreated muscle did. The authors describe the enzyme as a promising drug target because it rises with age and limits repair. They suggest that pairing a blocker of this enzyme with GLP-1 treatment could help patients lose fat while keeping muscle.
Catalog record
| CREATOR | Minas Nalbandian, Jameel Lone, Emmeran Le Moal, Ireh Kim, Kaitlin Jeuris, Yutong Kelly Li, Peggy Kraft, Meng Zhao, Kassie Koleckar, Zeyuan Zhang, Katrin J. Svensson, Helen M. Blau |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |